Chikungunya vaccine candidate enters Phase 2/3 trial 26-Aug-2021 By Rachel Arthur The International Vaccine Institute (IVI) and Bharat Biotech have started a Phase 2/3 clinical trial for a chikungunya vaccine candidate in Costa Rica.